Literature DB >> 24408568

Cancer screening in the United States, 2014: a review of current American Cancer Society guidelines and current issues in cancer screening.

Robert A Smith1, Deana Manassaram-Baptiste, Durado Brooks, Vilma Cokkinides, Mary Doroshenk, Debbie Saslow, Richard C Wender, Otis W Brawley.   

Abstract

Answer questions and earn CME/CNE Each year the American Cancer Society publishes a summary of its guidelines for early cancer detection, a report on data and trends in cancer screening rates, and select issues related to cancer screening. In this issue of the journal, we summarize current American Cancer Society cancer screening guidelines. In addition, the latest data on the use of cancer screening from the National Health Interview Survey is described, as are several issues related to screening coverage under the Patient Protection and Affordable Care Act, including the expansion of the Medicaid program.
© 2014 American Cancer Society, Inc.

Entities:  

Keywords:  American Cancer Society; United States; diagnosis; humans; lung neoplasms; mass screening; mortality; neoplasms; practice guidelines as topic; prevention and control; radiography

Mesh：

Year:  2014        PMID： 24408568     DOI： 10.3322/caac.21212

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN： 0007-9235            Impact factor:   508.702


  75 in total

1.  Association between persistence with mammography screening and stage at diagnosis among elderly women diagnosed with breast cancer.

Authors:  Ami Vyas; Suresh Madhavan; Usha Sambamoorthi
Journal:  Breast Cancer Res Treat       Date:  2014-11-16       Impact factor: 4.872

2.  Editorial: Colorectal Cancer Screening Education in Medically Vulnerable Populations: the Role of the Journal of Cancer Education.

Authors:  John T Vetto
Journal:  J Cancer Educ       Date:  2015-12       Impact factor: 2.037

3.  Baseline Attitudes About Prostate Cancer Screening Moderate the Impact of Decision Aids on Screening Rates.

Authors:  Amy J Starosta; George Luta; Catherine A Tomko; Marc D Schwartz; Kathryn L Taylor
Journal:  Ann Behav Med       Date:  2015-10

4.  Pre-screening Discussions and Prostate-Specific Antigen Testing for Prostate Cancer Screening.

Authors:  Jun Li; Guixiang Zhao; Ingrid J Hall
Journal:  Am J Prev Med       Date:  2015-05-18       Impact factor: 5.043

5.  Long non-coding RNA CARLo-5 is a negative prognostic factor and exhibits tumor pro-oncogenic activity in non-small cell lung cancer.

Authors:  Jie Luo; Liang Tang; Jie Zhang; Jian Ni; Hai-ping Zhang; Ling Zhang; Jian-fang Xu; Di Zheng
Journal:  Tumour Biol       Date:  2014-08-17

6.  Associations between provider designation and female-specific cancer screening in women Veterans.

Authors:  Bevanne Bean-Mayberry; Lori Bastian; Mark Trentalange; Terrence E Murphy; Melissa Skanderson; Heather Allore; Evelyn Reyes-Harvey; Natalya C Maisel; Vera Gaetano; Steven Wright; Sally Haskell; Cynthia Brandt
Journal:  Med Care       Date:  2015-04       Impact factor: 2.983

7.  Should Never-Smokers at Increased Risk for Lung Cancer Be Screened?

Authors:  Kevin Ten Haaf; Harry J de Koning
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

8.  Adherence to Multiple Cancer Screening Tests among Women Living in Appalachia Ohio.

Authors:  Mira L Katz; Paul L Reiter; Gregory S Young; Michael L Pennell; Cathy M Tatum; Electra D Paskett
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-08-17       Impact factor: 4.254

9.  Patient and Physician Factors Associated with Undisclosed Prostate Cancer Screening in a Sample of Predominantly Immigrant Black Men.

Authors:  Stephen J Lepore; Rasmi G Nair; Stacy N Davis; Randi L Wolf; Charles E Basch; Nigel Thomas; Celia Shmukler; Ralph Ullman
Journal:  J Immigr Minor Health       Date:  2017-12

10.  Up-regulation of long non-coding HOTTIP functions as an oncogene by regulating HOXA13 in non-small cell lung cancer.

Authors:  Yulan Sang; Fucheng Zhou; Dongjie Wang; Xin Bi; Xuanxi Liu; Zhen Hao; Qingsong Li; Wei Zhang
Journal:  Am J Transl Res       Date:  2016-05-15       Impact factor: 4.060
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.